Collegium Pharmaceutical, Inc

COLL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001267565

SEC filings (opens in a new tab)

No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Collegium Pharmaceutical, Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of COLL: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	155	1	159	+5
Shares	36.4M	30.1K	35.8M	−591.2K (−1.6%)
Value	$719.5M	$594.0K	$669.4M	−$49.5M (−6.9%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Collegium Pharmaceutical, Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to COLL in Q4 2021
Institution	Shares	Value	% of portfolio
Jefferies Group LLC	160,885	$3.01M	0.06%
SEI Investments Co	154,298	$2.88M	0.01%
Allspring Global Investments Holdings, LLC	81,059	$1.51M	0.00%
Yousif Capital Management, LLC	35,307	$660.0K	0.01%
Factorial Partners, LLC	33,300	$622.0K	0.41%
Diametric Capital, LP	18,064	$537.0K	0.41%
ExodusPoint Capital Management, LP	28,621	$535.0K	0.01%
HRT Financial LP	28,534	$533.0K	0.00%
Lazard Asset Management LLC	20,935	$391.0K	0.00%
Susquehanna International Group, LLP	17,217	$322.0K	0.00%
Squarepoint Ops LLC	14,889	$278.0K	0.00%
Ergoteles LLC	11,711	$219.0K	0.01%
Euclidean Technologies Management, LLC	10,900	$204.0K	0.17%
Prelude Capital Management, LLC	10,796	$202.0K	0.01%
Campbell & CO Investment Adviser LLC	10,000	$187.0K	0.06%
State of Wyoming	3,519	$66.0K	0.03%
Denali Advisors LLC	1,700	$32.0K	0.01%
Aquatic Capital Management LLC	400	$7.00K	0.01%
EverSource Wealth Advisors, LLC	190	$4.00K	0.00%
Eaton Vance Management	91	$2.00K	0.00%
Massmutual Trust Co FSB	31	$1.00K	0.00%
Covestor Ltd	34	$1.00K	0.00%
Sutton Wealth Advisors Inc.	11	$205	0.00%
Parallel Advisors, LLC	15	$0	0.00%
Rockefeller Capital Management L.P.	31	$0	0.00%

Sold out (20)

Institutions that held Collegium Pharmaceutical, Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of COLL in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Great Point Partners LLC	121,342	$2.40M
Manchester Capital Management LLC	69,535	$1.37M
Millennium Management LLC	54,099	$1.07M
Renaissance Group LLC	47,140	$931.0K
Foundry Partners, LLC	46,230	$913.0K
Cambridge Associates LLC	25,524	$504.0K
Citadel Advisors LLC	23,933	$473.0K
Crossmark Global Holdings, Inc.	21,200	$418.0K
Trexquant Investment LP	18,549	$366.0K
Allianz Asset Management GmbH	14,521	$287.0K
Dynamic Technology Lab Private Ltd	14,489	$286.0K
Susquehanna Fundamental Investments, LLC	12,200	$241.0K
DekaBank Deutsche Girozentrale	10,400	$204.0K
O'Shaughnessy Asset Management, LLC	1,652	$33.0K
Penserra Capital Management LLC	815	$16.0K
Proequities, Inc.	491	$10.0K
Simplex Trading, LLC	248	$5.00K
Evolution Wealth Advisors, LLC	211	$4.00K
Meridian Wealth Partners, LLC	6	$0
Kowal Investment Group, LLC	1	$0

Not filed for Q4 2021 yet (1)

Institutions that held Collegium Pharmaceutical, Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding COLL in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
HighPoint Advisor Group LLC	30,077	$594.0K